Maryam Foroozesh to Ceramides
This is a "connection" page, showing publications Maryam Foroozesh has written about Ceramides.
Connection Strength
3.104
-
Ponnapakkam T, Saulsberry T, Hill-Odom M, Beamon T, Hooks R, Goyal N, Shaik S, Anbalagan M, Foroozesh M. Anti-cancer effectiveness of a novel ceramide analog on chemo-sensitive and chemo-resistant breast cancers. Anticancer Drugs. 2024 01 01; 35(1):12-21.
Score: 0.894
-
Ponnapakkam T, Saulsberry T, Hill T, Hill-Odom M, Goyal N, Anbalagan M, Liu J, Foroozesh M. Inhibition of breast tumor growth in mice after treatment with ceramide analog 315. Anticancer Drugs. 2018 10; 29(9):898-903.
Score: 0.638
-
Liu J, Beckman BS, Foroozesh M. A review of ceramide analogs as potential anticancer agents. Future Med Chem. 2013 Aug; 5(12):1405-21.
Score: 0.446
-
Liu J, Antoon JW, Ponnapakkam A, Beckman BS, Foroozesh M. Novel anti-viability ceramide analogs: design, synthesis, and structure-activity relationship studies of substituted (S)-2-(benzylideneamino)-3-hydroxy-N-tetradecylpropanamides. Bioorg Med Chem. 2010 Jul 15; 18(14):5316-22.
Score: 0.359
-
Antoon JW, Liu J, Gestaut MM, Burow ME, Beckman BS, Foroozesh M. Design, synthesis, and biological activity of a family of novel ceramide analogues in chemoresistant breast cancer cells. J Med Chem. 2009 Sep 24; 52(18):5748-52.
Score: 0.341
-
Chen J, Goyal N, Dai L, Lin Z, Del Valle L, Zabaleta J, Liu J, Post SR, Foroozesh M, Qin Z. Developing new ceramide analogs and identifying novel sphingolipid-controlled genes against a virus-associated lymphoma. Blood. 2020 11 05; 136(19):2175-2187.
Score: 0.184
-
Ponnapakam AP, Liu J, Bhinge KN, Drew BA, Wang TL, Antoon JW, Nguyen TT, Dupart PS, Wang Y, Zhao M, Liu YY, Foroozesh M, Beckman BS. 3-Ketone-4,6-diene ceramide analogs exclusively induce apoptosis in chemo-resistant cancer cells. Bioorg Med Chem. 2014 Feb 15; 22(4):1412-20.
Score: 0.115
-
Antoon JW, Liu J, Ponnapakkam AP, Gestaut MM, Foroozesh M, Beckman BS. Novel D: -erythro N-octanoyl sphingosine analogs as chemo- and endocrine-resistant breast cancer therapeutics. Cancer Chemother Pharmacol. 2010 May; 65(6):1191-5.
Score: 0.088
-
Dai L, Smith CD, Foroozesh M, Miele L, Qin Z. The sphingosine kinase 2 inhibitor ABC294640 displays anti-non-small cell lung cancer activities in vitro and in vivo. Int J Cancer. 2018 05 15; 142(10):2153-2162.
Score: 0.038